How Much Does CancerGuard Cost?
Published on | Written by Alec Pow
This article was researched using 14 sources. See our methodology and corrections policy.
CancerGuard is a multi-cancer early detection blood test from Exact Sciences that runs through a clinician-ordered lab workflow and can trigger follow-up imaging if a cancer signal is reported. The headline number is the self-pay test charge, but the total you spend can jump if results lead to radiology, specialist consults, and tissue confirmation.
For budget planning, treat the total as two parts: the one-time test charge, then any downstream medical workup that can include imaging and follow-on procedures ordered by your care team. In a September 2025 investor release, Exact Sciences says the test is priced at $689 and that payment plans are available, and spreading $689 across 12 months works out to about $57.42 per month because $689 divided by 12 equals $57.42.
CancerGuard is billed per test order, and the ordering channel can change what shows up on your statement. The biggest swing factor is follow-up imaging and specialty workups if a positive cancer signal needs to be located and confirmed.
Plan on a self-pay screening charge plus potentially larger follow-up imaging bills if a signal is detected.
Important numbers
Jump to sections
- Out-of-pocket list price is $689 in launch-era reporting. Reported out-of-pocket
- Turnaround is about 2 weeks for provider review. Results are ready
- Potential support after a positive result includes an imaging reimbursement program that can reimburse up to $6,000 for non-covered imaging costs. Imaging reimbursement program
How Much Does CancerGuard Cost?
The clearest published number is the self-pay price, and the patient FAQ lists the self-pay price as $689 and says pricing can change, while also stating there is no additional cost to use Exact Sciences-managed phlebotomy services if you need help getting the blood draw done.
Blood draw logistics can still affect the practical experience, since you may need to schedule an appointment, travel to a collection site, or coordinate timing with your clinician’s office. Follow-up imaging and other medical tests are billed separately if a cancer signal is detected.
What we verified
- Checked third-party launch coverage that repeats the listed $689 price.
- Confirmed biomarker framing and published $689 pricing in a research foundation explainer.
- Cross-referenced an investment-style research note describing CancerGuard as an LDT priced at $689 on a commercialization summary.
What this is in plain terms
This is a screening blood test that looks for cancer-associated signals across multiple cancers, then reports whether a signal was detected. The workflow looks like screening plus follow-up, not a single definitive answer, and the test is positioned as something you do in addition to standard screenings you already get through your doctor.
Exact Sciences describes it as a multi-cancer early detection test ordered through a provider workflow, which makes it closer to a lab-developed clinical test than a consumer gadget.
Ordering and insurance, who bills you
There are two practical paths: your own clinician orders the test through their system, or you request it online and complete a telehealth step before an order is placed. The consumer request page says the telehealth provider relationship is separate from Exact Sciences, that the telehealth service is included in the total $689 price, and that the test is not currently covered by health insurance and is not yet available in New York state.
Even if you order it through your own clinician, billing can still split between the lab test itself and any visit or follow-up care your provider recommends after the report comes back.
Follow-up steps after a positive signal
A positive result is not a diagnosis, so the next phase is often imaging and targeted diagnostic workup directed by your care team, and that is where totals can move from a single lab bill into a multi-visit medical sequence across radiology, specialty consults, and pathology. STAT News reported at launch that follow-up for this test can include CT or PET imaging used to locate a potential cancer source.
| Cost layer | Who bills it | Why it shows up |
|---|---|---|
| Screening test charge | Exact Sciences pathway | Self-pay purchase and lab processing |
| Ordering visit | Clinic or telehealth partner | Medical order and review of eligibility |
| Imaging workup | Radiology provider | Locating a suspected cancer signal |
| Biopsy and pathology | Facility and lab | Confirming diagnosis if imaging finds a target |
This is the part many buyers miss when they only compare list prices. Imaging, sedation, facility fees, and pathology can each become their own bill, and the timing depends on how fast your local system schedules diagnostic slots after a positive screening signal.
Add-on costs
The fastest way for your total to climb is imaging plus tissue confirmation. A broad MRI pricing rundown shows ranges as wide as $400 to $12,000 depending on setting and scan type.
Biopsies can also add meaningful cost depending on method and site, with one breakdown listing examples such as shave biopsy $100 to $300 and punch biopsy $200 to $500.
Hidden-cost range check
- Imaging can be the largest swing factor, not the blood test itself.
- Procedures and pathology can stack once imaging finds a target.
- Case 1 Self-pay screening only You pay the one-time test charge and your clinician files it as an optional screening order with no further workup.
- Case 2 Positive signal with imaging A positive signal leads to a radiology workup, and your cash outlay becomes test plus imaging bills.
- Case 3 Positive signal with biopsy Imaging finds a target and your total adds facility, pathology, and specialist visit costs on top of the screening and imaging.
Some shoppers compare this spending to other screening-style products. For stool DNA screening, the cash-pay anchor in one comparison is the $790 self-pay price shown for Cologuard Plus, which highlights how screening products can still be expensive even before follow-up care. For whole-body scanning, Prenuvo’s published pricing is another reference point, with a $2,500 full-body MRI scan and a $3,999 more comprehensive package cited in one breakdown.
Worked example
Using the published $689 self-pay price and the PET scan cash range of $1,323 to $4,525, the low-end pairing is $2,012 because $689 plus $1,323 equals $2,012, and the high-end pairing is $5,214 because $689 plus $4,525 equals $5,214, so the imaging swing alone is $3,202.
- Screening test is $689
- Imaging example range is $1,323 to $4,525
- Modeled total with one PET scan is $2,012 to $5,214
What changes your total most
Four levers move the total: how you order it, whether a clinician visit is billed separately, whether a positive result triggers imaging, and whether imaging triggers biopsy and pathology. The more your path looks like diagnostic medicine, the more your costs resemble radiology and procedure bills rather than a single lab charge.
Even simple lab work can be priced separately from visits and imaging, and broader lab pricing can span from small panels to specialized tests depending on what is ordered.
Who this cost makes sense for
Many buyers treat this as optional screening, then accept the possibility that a positive signal triggers more healthcare spending. It is self-pay. Bills can stack fast. Harvard Health notes that multi-cancer early detection blood tests can produce false positives and false negatives, which is one reason follow-up testing becomes part of the cost story.
Makes sense if
- You can pay the self-pay charge without relying on insurance reimbursement.
- A clinician is ready to manage follow-up steps if a signal is detected.
- You understand that screening is not a diagnosis and still commit to routine screenings.
- You want extra screening coverage for cancers that do not have routine screening programs.
Doesn’t make sense if
- You need predictable copays and only want tests billed through insurance.
- You are not willing to pursue imaging or specialist workup after a positive result.
- You are looking for a substitute for standard guideline-based screenings.
- You want a test that confirms cancer rather than a screening signal.
Decision support comes down to risk tolerance and follow-through. A negative result can still lead you back to routine screening, and a positive result can start a multi-visit process that is priced like diagnostic medicine, not a retail lab kit.
Article Highlights
- Exact Sciences lists CancerGuard at $689 as a self-pay purchase.
- The biggest cost swing is follow-up imaging and any procedures that follow.
- Ordering channel can change whether you also see a clinic or telehealth bill.
- Budgeting works better with a low-follow-up and high-follow-up scenario.
- Standard screenings still matter because this test is not a diagnosis.
Answers to Common Questions
Is CancerGuard covered by insurance?
Exact Sciences’ consumer request page says it is not currently covered by health insurance, so many buyers treat it as self-pay.
Does a positive result mean you have cancer?
No. The company and third-party explainers describe it as a screening signal that can lead to imaging and other tests to locate and confirm a diagnosis.
How fast do results come back?
Company materials commonly describe results being ready in about two weeks for review with a healthcare provider.
Can follow-up costs exceed the test price?
Yes. Imaging and procedures can carry their own facility and professional fees, which can outsize the one-time screening charge.
Disclosure: Educational content, not medical advice. Pricing varies by provider, location, and insurance. Confirm eligibility, coverage, and out-of-pocket costs with a licensed clinician and your insurer.